Esperion Therapeutics (NASDAQ:ESPR) executives told investors the company delivered its “strongest performance to date” in ...

Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is ...

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.

A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.

Many of us take medications to relieve pain, fight infections, or manage chronic conditions. While these therapies offer important health benefits, it's worth understanding a lesser-known ...

Earnings call Esperion posted its strongest quarter ever, with Q4 revenue up 144% YoY and U.S. net product sales rising 38%. The planned Corstasis acquisition, strong cash position, and imminent U.S.

Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today's conference call will be recorded. I would now like to hand the conference over to ...

Purging behaviors (vomiting or misuse of laxatives, diuretics, or enemas) can also shift from conscious decisions to automatic routines. Early motivations might include concerns about weight or relief ...

K Tyler Loop on missing a 44-yard field goal in the AFC North title game against the Steelers, the support he has from the organization, and more. K Tyler Loop on missing a 44-yard field goal in the ...